Technologies and treatments for patients with debilitating musculoskeletal diseases have seen rapid advances in recent years, but are still plagued by complications in drug delivery which can reduce effectiveness or cause unintended effects. Erica Wagner’s goal is to engineer biomaterials for targeted drug delivery systems that can sustain long-lasting effects and minimize off-target activity. Erica, a member of the Honors Program, has undertaken several projects related to the development of such biomaterials in the Molecular Bioelectrostatics & Drug Delivery Lab of Professor Ambika Bajpayee. With the support of an Undergraduate Research and Creative Endeavor Award, Erica extended the lab’s research on osteoarthritic tissue degeneration from cartilage to the less commonly studied intervertebral disc tissue. On co-op at Visterra Inc., Erica approached research from the perspective of a biotechnology company and worked on glomerulonephritis, the inflammation of the membrane tissue in the kidney which leads to kidney failure. This experience helped confirm her aspiration to work in industry after earning her PhD in bioengineering, continuing her drive for drug development, most likely in coordination with an academic lab.